Simpson Thacher represented EQT Mid Market U.S. fund (“EQT Mid Market U.S.”) in connection with its acquisition of a majority stake in Clinical Innovations, the leading global, pure-play provider of single-use clinician-preferred medical devices for Labor & Delivery departments within hospitals. The financial terms of the transaction have not been disclosed.
The Simpson Thacher team included Robert Langdon, Michael Holick, Fred De Albuquerque, Colin Lloyd, Sherry Shen and Blake Meyer (M&A); Chris Brown, James Doyle, Jim Russell and Richard Ragusa (Credit); Larry Moss, Jeannine McSweeney, Patricia Adams and Jake Phillips (ECEB); Jason Glover, Vasanth Padaki and Robert Lee (Funds); Jonathan Goldstein and Jasmine Hay (Tax); Jeffrey Ostrow, Marcela Robledo, Linda Nyberg and Marissa Lambert (IP); Sara Razi, Kelly Karapetyan, Ellen Frye and Muran Zhu (Antitrust); and Michael Isby (Environmental).